SAMUEL FOX: Open Payments
NPI 1003381633 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,722 in 134 payments from 17 companies in 2025. Trend: 2023 $2,851 · 2024 $3,129 · 2025 $2,722
Food & beverage: $2,622Education: $100
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 29 | $817 |
| Novartis Pharmaceuticals Corporation | 13 | $302 |
| Incyte Corporation | 17 | $264 |
| Regeneron Healthcare Solutions, Inc. | 12 | $228 |
| ABBVIE INC. | 16 | $225 |
| Galderma Laboratories, L.P. | 14 | $165 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $160 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 6 | $116 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| Organon LLC | 4 | $81 |
Products named: ADBRY, ANZUPGO, OPZELURA, DUPIXENT, SKYRIZI, COSENTYX, JUBLIA, Winlevi.
Industry payments across AZ — which companies pay providers there.
